S
Shailendra Saraf
Researcher at Pandit Ravishankar Shukla University
Publications - 77
Citations - 4821
Shailendra Saraf is an academic researcher from Pandit Ravishankar Shukla University. The author has contributed to research in topics: Drug delivery & Drug carrier. The author has an hindex of 29, co-authored 73 publications receiving 3696 citations. Previous affiliations of Shailendra Saraf include P.G. College.
Papers
More filters
Journal ArticleDOI
Limonoids: Overview of significant bioactive triterpenes distributed in plants kingdom
Amit Roy,Shailendra Saraf +1 more
TL;DR: Limonoids are highly oxygenated, modified terpenoids with a prototypical structure either containing or derived from a precursor with a 4,4,8-trimethyl-17-furanylsteroid skeleton and their occurrence in the plant kingdom is confined to only plant families of order Rutales.
Journal ArticleDOI
Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
Amit Alexander,Shubhangi Dwivedi,Ajazuddin,Tapan Kumar Giri,Swarnlata Saraf,Shailendra Saraf,Dulal Krishna Tripathi +6 more
TL;DR: This review focuses on the recent advancements in the TDDS which include iontophoresis, sonophores is, electroporation, microneedles, magnetophoreis, photomechanical waves and electron beam irradiation.
Journal ArticleDOI
Nanocarriers: Promising Vehicle for Bioactive Drugs
TL;DR: This review highlights the different types of nanoparticulate delivery systems employed for biotech drugs in the field of molecular medicine with a short overlook at its applications and the probable associated drawbacks.
Journal ArticleDOI
Cyclodextrin based novel drug delivery systems
TL;DR: Applications and comparative benefits of use of cyclodextrins (CDs) and their derivatives in the design of novel delivery systems like liposomes, microspheres, microcapsules, nanoparticles,cyclodextrin grafted cellulosic fabric, hydrogels, nanosponges, beads, nanogels/nanoassemblies and cyclodeXTrin-containing polymers are outlined.
Journal ArticleDOI
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Mukta Agrawal,Swarnlata Saraf,Shailendra Saraf,Sophia G. Antimisiaris,Mahavir B. Chougule,Sunday A. Shoyele,Amit Alexander +6 more
TL;DR: The latest works on various novel formulations loaded with various anti‐Alzheimer agents are discussed, which underlines the fact that majority of work related to the nose‐to‐brain delivery of anti‐AD drugs is limited only up to preclinical studies.